Chief, Hematology-Oncology - Francis J. Giles, MB, MD, FRCPI, FRCPath
Francis J. Giles, MB, MD, FRCPI, FRCPath is Professor of Medicine and Chief of the Division of Hematology/Oncology at Northwestern University Feinberg School of Medicine. A cancer specialist with more than two decades of experience, Dr. Giles has led the development of novel drugs, immunotherapies, and other highly targeted approaches, including cancer-directed viruses, monoclonal antibodies, and molecularly directed agents. He has served as principal investigator on numerous national and international First in Human, Phase I, II, and III clinical studies of many novel agents, and holds numerous patents and technology licenses.
As Director of Developmental Therapeutics, Dr. Giles has focused his clinical and research efforts on providing therapy for patients suffering from treatment-resistant or refractory cancer. He has pioneered the use of many agents that are now in regular use as targeted therapies for patients with cancer. Among his many accolades, Dr. Giles was recently elected as a Fellow of the European Academy of Cancer Sciences. He is also a Fellow of the Royal College of Physicians of Ireland and the Royal College of Pathologists (UK). He has over 500 peer-reviewed publications focused on oncology developmental therapeutics. Dr. Giles has particular interests in the mentoring of developmental therapeutics physician-scientists and in international collaborations across the bioscience spectrum.